TWM
ABBV icon

Thrive Wealth Management’s AbbVie ABBV Stock Holding History

Thrive Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Sell
5,708
-255
-4% -$54.9K 0.18% 61
2026
Q1 		$1.3M Buy
5,963
+152
+3% +$33.7K 0.19% 57
2025
Q4 		$1.33M Buy
5,811
+177
+3% +$40.3K 0.2% 57
2025
Q3 		$1.3M Buy
5,634
+67
+1% +$13.6K 0.2% 54
2025
Q2 		$1.03M Sell
5,567
-413
-7% -$76.8K 0.17% 70
2025
Q1 		$1.25M Sell
5,980
-222
-4% -$43.2K 0.24% 49
2024
Q4 		$1.1M Buy
6,202
+42
+0.7% +$7.72K 0.2% 58
2024
Q3 		$1.22M Sell
6,160
-7
-0.1% -$1.31K 0.22% 57
2024
Q2 		$1.06M Sell
6,167
-196
-3% -$32.5K 0.21% 56
2024
Q1 		$1.16M Buy
6,363
+578
+10% +$99.6K 0.24% 52
2023
Q4 		$896K Sell
5,785
-331
-5% -$48.3K 0.2% 66
2023
Q3 		$912K Buy
6,116
+544
+10% +$79.9K 0.24% 55
2023
Q2 		$751K Buy
5,572
+1,034
+23% +$152K 0.19% 76
2023
Q1 		$723K Buy
4,538
+76
+2% +$11.6K 0.19% 69
2022
Q4 		$721K Buy
4,462
+965
+28% +$148K 0.21% 60
2022
Q3 		$469K Buy
3,497
+106
+3% +$15.2K 0.16% 82
2022
Q2 		$519K Buy
3,391
+318
+10% +$48.6K 0.18% 73
2022
Q1 		$498K Buy
3,073
+723
+31% +$105K 0.15% 80
2021
Q4 		$318K Buy
+2,350
New +$278K 0.11% 117

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Thrive Wealth Management's ABBV Position: Q2 2026 in Review

Thrive Wealth Management reduced its AbbVie (ABBV) stake by 4.3% in Q2 2026, selling an estimated $54.9K and leaving 5,708 shares worth $1.44M. The position accounts for 0.18% of the portfolio, ranked #61.

Thrive Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Thrive Wealth Management held 5,708 shares of AbbVie worth $1.44M as of Q2 2026.
  • Thrive Wealth Management sold 255 AbbVie shares in Q2 2026, an estimated $54.9K.
  • AbbVie made up 0.18% of Thrive Wealth Management's portfolio in Q2 2026, its #61 holding.
  • Thrive Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Thrive Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.